Deltaclav 457 mg Powder for Oral Suspension

Deltaclav 457 mg Suspension:
Amoxicillin Trihydrate+Potassium Clavulanate.
Dry Mix.

ADDITIONAL INFORMATION

Composition:
  • – Amoxicillin trihydrate 460 mg equivalent to amoxicillin 400 mg.
  • – Potassium clavulanate 67.83mg equivalent to clavulanic acid 57 mg.
Indications:
  • – Acute bacterial sinusitis (adequately diagnosed).
  • – Acute otitis media.
  • – Acute exacerbations of chronic bronchitis (adequately diagnosed).
  • – Community acquired pneumonia.
  • – Cystitis.
  • – Pyelonephritis.
  • – Skin and soft tissue infections in particular cellulitis, animal bites, severe dental abscess with spreading cellulitis.
  • – Bone and joint infections, in particular osteomyelitis.
Dosage and Administration:
  • – 25 mg – 45 mg kg/day given as two divided doses.
  • – Up to 70 mg/10 mg/kg/day given as two divided doses may be considered for some infections (such as otitis media, sinusitis and lower respiratory tract infections).
  • – No clinical data are available for Deltaclav 7:1 formulation regarding doses higher than 45 mg/6.4 mg per kg per day in children less than 2 years.
  • – There are no clinical data for Deltaclav 7:1 formulation for patients fewer than 2 months of age. Dosing recommendations in this population therefore cannot be made.
  • – Deltaclav is for oral use.
Package: Carton box containing a glass bottle of 80 ml suspension after reconstitution.

Additional Information

human

human


Reviews

There are no reviews yet.

Be the first to review “Deltaclav 457 mg Powder for Oral Suspension”





Address


Delta Pharma

28 Farid St. Behined Meridien Heliopolis, Cairo, Egypt.



Delta Pharma Factory

Industrial Zone B4,10th of Ramadan City, Egypt.



Send Us


Telephone

info@dp.eg



Send C.V.

Send your CV to: careers@dp.eg


Contact


Telephone

(202) 24142500
(205) 54501211



Fax

(202) 24179962
(205) 54501256



Sales Department

+20 1111000656




DELTA PHARMA is a leading pharmaceutical company in the Egyptian market aiming to step up its rank among all other Arabian pharmaceutical manufacturers, to be one of the top ten generic companies in the region within the upcoming years.

© Copyright Delta Pharma 2024. All rights reserved.